Cognitive Impairment Is Best Predictor of Poor Driving by Patients
A poor performance, due to cognitive impairments, on the Rookwood Driving Battery (RDB) — a set of tests aiming…
Articles by Joana Carvalho, PhD
PKG Device Shown to Detect Abnormal Movements in Parkinson’s, Bradykinesia
The Parkinson’s Personal KinetiGraph (PKG), a small motion sensor device that can be worn on the wrist like a…
Eisai Partners With Wren to Discover New Therapies for Parkinson’s, Other Diseases
Eisai is partnering with Wren Therapeutics to advance the discovery of new small molecule compounds capable of reducing…
Parkinson’s UK, Fox Foundation Supporting Trial of NLX-112 to Ease Dyskinesia
Two nonprofits, Parkinson’s U.K. and The Michael J. Fox Foundation have partnered with Neurolixis to support a clinical trial…
Levodopa and Its Infused Gel Form Affect Gut Bacteria, May Promote Inflammation
Levodopa, and especially levodopa/carbidopa intestinal gel (LCIG) — a formulation of levodopa and carbidopa infused directly into…
Alterity’s Next-generation Compounds for Brain Diseases Granted US Patent
The U.S. Patent and Trademark Office (USPTO) has issued a patent covering the intellectual rights to…
Anavex 2-73 Safely Aids Cognition in Parkinson’s Dementia, Phase 2 Trial Shows
Anavex 2-73 (blarcamesine) safely led to significant improvements in several aspects of cognition, including choice reaction time and…
Dopamine and Serotonin Play Key Role in Perception and Cognition, Study Finds
Dopamine and serotonin — two brain chemicals involved in reward processing and whose pathways are treatment targets for diseases…
Certain Diabetes Medications Linked to Lower Parkinson’s Risk, Study Suggests
Certain types of anti-diabetic medications may lower the risk of Parkinson’s disease in people with type 2 diabetes,…
Simvastatin Fails to Slow Parkinson’s Progression, Trial Data Shows
Simvastatin, a widely-used cholesterol-lowering medication, failed to slow the progression of Parkinson’s disease, according to data from…